TTOO News and Press, T2 Biosystems Inc. From 09/29/22

LEXINGTON, Mass., Sept. 29, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that the Biomedical Advanced Research and Development Authority (BARDA), part of the Offi...

T2 Biosystems ( NASDAQ: TTOO ) on Thursday said it had entered into a distribution agreement in the Baltic region for the sale of its products. Shares of the micro-cap diagnostics company jumped 17.3% to $0.10 after hours. It is worth noting that TTOO stock had ear...

LEXINGTON, Mass., Sept. 22, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the execution of a territory exclusive distribution agreement in the Baltic Region, including L...

LEXINGTON, Mass., Sept. 08, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced plans to participate in the upcoming H.C. Wainwright Global Investment Conference in New ...

Summary T2's ongoing survival is a marvel to behold. T2's products fill key niches but have yet to show any viable commercial appeal. The elephant in the room for T2 shareholders is whether it will ever participate in any upside that may reside in its intellectual property. ...

Which penny stocks are at the top of your list today? If you’ve seen some of the biggest gapping stocks of the day, you’ll see several that we’ve discussed right here on PennyStocks.com have exploded over the last few sessions. Companies like Bright Minds Biosciences ( ...

T2 Biosystems, Inc. (TTOO) CEO Q2 2022 Results Earnings Conference Call August 15, 2022, 04:30 PM ET Company Participants Emma Poalillo - Investor Relations, Gilmartin Group John Sperzel - Chairman and Chief Executive Officer John Sprague - Chief Financial Office...

T2 Biosystems ( NASDAQ: TTOO ) Q2 2022 results missed on the top and bottom lines , though the in-vitro diagnostics company maintained its 2022 revenue outlook. Shares are down 8% in post-market trading. T2 ( TTOO ) expects full-year revenue of $28M-$31M, i...

T2 Biosystems press release ( NASDAQ: TTOO ): Q2 GAAP EPS of -$0.10 misses by $0.01 . Revenue of $5.91M (-11.7% Y/Y) misses by $0.22M . Cash, cash equivalents and restricted cash were $14.3 million as of June 30, 2022. Shares +5.17% . For further ...

LEXINGTON, Mass., Aug. 15, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced financial results for the second quarter ended June 30, 2022...